600+ sources. One page. See who else covered it.
(MedPage Today) -- The FDA granted accelerated approval to vusolimogene oderparepvec (Tudriqev), known as RP1, in combination with nivolumab (Opdivo) to treat adults with unresectable advanced cutaneous melanoma, the agency announced Thursday...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Michigan has seen the worst of the outbreak, reporting the first two associated deaths this week. Both individuals had significant underlying health conditions.
Compared with standard flu shots, Moderna’s mFlusiva generates stronger, longer-lasting immunity and is more effective at preventing infection, data show.
The head of the Africa Centres for Disease Control pledged to deploy a vaccine for a previous Ebola strain in the current DRC outbreak, with test cases indicating a potentially live-saving level of…
The Deputy Minister for Health, Dr Grace Ayensu-Danquah, has disclosed that 986 pregnant women died in Ghana in 2024, with the country's maternal mortality ratio standing at 235 deaths per 100,000…
The first evidence that night work and chronic insomnia may increase the risk of developing long COVID comes from a new study led by ISGlobal, a center supported by the "la Caixa" Foundation, in…
The two Democrats criticized the administration's decision to terminate Medicare Part D premium subsidies.